DEBx Medical obtiene una mayor inversión de TVM Capital Healthcare
November 13, 2024 10:00 ET | DEBx Medical B.V.
DEBx Medical está preparada para un crecimiento acelerado en soluciones para heridas crónicas, reforzado por la segunda ronda de inversión de TVM Capital Healthcare. ÁMSTERDAM y DUBÁI,...
DEBx Medical Memperoleh Perluasan Investasi dari TVM Capital Healthcare
November 13, 2024 10:00 ET | DEBx Medical B.V.
DEBx Medical siap mendorong percepatan pertumbuhan dalam solusi luka kronis, yang didukung oleh babak investasi kedua dari TVM Capital Healthcare. AMSTERDAM dan DUBAI, Uni Emirat Arab, Nov. 13, 2024...
PBC BioVet
PBC BioVet: Eine neue Dimension in der tierärztlichen Versorgung
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Irland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed ist stolz darauf, sein neuestes Unternehmen, PBC BioVet, vorzustellen: eine engagierte Tochtergesellschaft, die darauf abzielt, die...
PBC BioVet
Présentation de PBC BioVet : une nouvelle frontière dans les soins de santé vétérinaires
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Irlande, 13 mai 2024 (GLOBE NEWSWIRE) -- PBC Biomed est fier de dévoiler son tout nouveau projet, PBC BioVet, une filiale entièrement dédiée aux soins vétérinaires. Fermement résolu à...
PBC BioVet
Introducing PBC BioVet: A New Frontier in Veterinary Healthcare
May 12, 2024 20:05 ET | PBC Biomed Ltd
SHANNON, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a...
Kane Logo Cropped TransBG.png
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
January 31, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Kane Logo Cropped TransBG.png
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
January 25, 2024 12:03 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
November 21, 2023 07:45 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Strengthens Board with Biotech Executive
November 16, 2023 13:45 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been...
3239-KAN-Revyve_Box&Tube_LG-d2-FL
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
November 02, 2023 11:48 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...